Facioscapulohumeral Muscular Dystrophy clinical trials at UCSD
1 in progress, 0 open to eligible people
Showing trials for
AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
Sorry, accepting new patients by invitation only
A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
San Diego, California and other locations